"The Impact of Healthcare Legislation on Infection Control," by Kathy Dix, page 30
"New IV Guidelines: What's Most Critical to Know," by Rita McCormick, RN, CIC and Laura Rutledge, RN, MN, CRNI, page 43
1. CDC, National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998; issued June 1998. Am J Infect Control. 1998; 26:522-33.
2. CDC, National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999; issued June 1999. Am J Infect Control. 1999; 27:520-32.
3. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991; 91 (suppl): S72-S75.
4. Rello J, Ochagavia A, Sabanes E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care 2000; 162:1027-30.
5. Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associates with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001; 136:229-34.
6. Mermel LA. Correction: catheter-related bloodstream infections. Ann Intern Med. 2000; 133:395.
7. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheter: a prospective study utilizing molecular subtyping. Am J Med 1991; 91 (suppl): S197-S205.
8. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994; 15:231-8.
9. Maki DG, Ringer M, Alvarado CJ. Prospective randomized trial of povidone-iodine, alcohol and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991; 338:339-43.
10. Humar A, Ostromecki A, Direnfeld J, et al. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection. Clin Infect Dis. 2000;31:1001-7.
11. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med. 1990; 18:1073-9.
12. Uldall PR, Merchant N, Woods F, Yarworski U, Vas S. Changing subclavian haemodialysis cannulas to reduce infection. Lancet. 1981; 1:1373.
13. Raad II, Darouiche R, Dupuis J, et al. Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonizations and bloodstream infections: a randomized, double-blind trial. The Texas Medical Center Catheter Study Group. Ann Intern Med 1997; 127:267-74.
14. Nehme AE. Nutritional support of the hospitalized patient: the team concept. JAMA 1980; 243:1906-8.
15. Soifer NE, Borzak S, Edline BR, Weinstein RA. Prevention of peripheral venous catheter complications with am intravenous therapy team: a randomized controlled trial. Arch Intern Med. 1998; 158:473-7.
16. Tomford JW, Hershey CO. The IV therapy team: impact on patient care and costs of hospitalization. NITA 1985; 8:387-9.